LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 3 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 3. - Dataset (ID:20311)

Filter results: >>>>
Cell Small Molecule Small Mol Concentration (uM) Time Point (hr) Total Cell Count Before Treatment Total Cell Count After Treatment Total Control Cell Count Relative Cell Count Normalized Growth Rate Inhibition Value Assay Plate Assay Well
MCF 10A-H2B-mCherry Trametinib
0.01
92.25 27.76 2424 6873 0.3527 0.7543
MN20160318_Q01
H06
MCF 10A-H2B-mCherry Trametinib
0.01
92.25 27.76 1956 6873 0.2846 0.7076
MN20160318_Q01
M14
MCF 10A-H2B-mCherry Trametinib
0.01
92.25 27.76 3583 6873 0.5213 0.8427
MN20160318_Q01
M14
MCF 10A-H2B-mCherry Trametinib
0.01
93.96 27.76 2409 6849 0.3517 0.7536
MN20160318_Q01
H06
MCF 10A-H2B-mCherry Trametinib
0.01
93.96 27.76 2450 6849 0.3577 0.7573
MN20160318_Q01
H06
MCF 10A-H2B-mCherry Trametinib
0.01
93.96 27.76 1998 6849 0.2917 0.7128
MN20160318_Q01
M14
MCF 10A-H2B-mCherry Trametinib
0.01
93.96 27.76 3755 6849 0.5483 0.8543
MN20160318_Q01
M14
MCF 10A-H2B-mCherry Trametinib
0.01
95.66 27.76 2439 6712 0.3633 0.7600
MN20160318_Q01
H06
MCF 10A-H2B-mCherry Trametinib
0.01
95.66 27.76 2492 6712 0.3712 0.7647
MN20160318_Q01
H06
MCF 10A-H2B-mCherry Trametinib
0.01
95.66 27.76 2008 6712 0.2991 0.7173
MN20160318_Q01
M14
MCF 10A-H2B-mCherry Trametinib
0.01
95.66 27.76 3848 6712 0.5733 0.8643
MN20160318_Q01
M14
MCF 10A-H2B-mCherry Trametinib
0.017783
1.95 27.76 1 225 0.0044 -0.6673
MN20160318_Q01
D08
MCF 10A-H2B-mCherry Trametinib
0.017783
1.95 27.76 479 225 2.1275 1.5681
MN20160318_Q01
D08
MCF 10A-H2B-mCherry Trametinib
0.017783
1.95 27.76 1 225 0.0044 -0.6673
MN20160318_Q01
N22
MCF 10A-H2B-mCherry Trametinib
0.017783
1.95 27.76 627 225 2.7849 1.8075
MN20160318_Q01
N22
MCF 10A-H2B-mCherry Trametinib
0.017783
3.66 27.76 1 283 0.0035 -0.6287
MN20160318_Q01
D08
MCF 10A-H2B-mCherry Trametinib
0.017783
3.66 27.76 541 283 1.9054 1.4238
MN20160318_Q01
D08
MCF 10A-H2B-mCherry Trametinib
0.017783
3.66 27.76 1 283 0.0035 -0.6287
MN20160318_Q01
N22
MCF 10A-H2B-mCherry Trametinib
0.017783
3.66 27.76 718 283 2.5288 1.6372
MN20160318_Q01
N22
MCF 10A-H2B-mCherry Trametinib
0.017783
5.36 27.76 1 320 0.0031 -0.6101
MN20160318_Q01
D08
MCF 10A-H2B-mCherry Trametinib
0.017783
5.36 27.76 607 320 1.8948 1.3971
MN20160318_Q01
D08
MCF 10A-H2B-mCherry Trametinib
0.017783
5.36 27.76 3 320 0.0094 -0.4677
MN20160318_Q01
N22
MCF 10A-H2B-mCherry Trametinib
0.017783
5.36 27.76 815 320 2.5440 1.6059
MN20160318_Q01
N22
MCF 10A-H2B-mCherry Trametinib
0.017783
7.06 27.76 1 360 0.0028 -0.5930
MN20160318_Q01
D08
MCF 10A-H2B-mCherry Trametinib
0.017783
7.06 27.76 687 360 1.9083 1.3820
MN20160318_Q01
D08